These data imply that myeloid TLR4 plays a regulatory role in adaptive immunity and deletion of macrophage tlr4 can alter the T cell immunity by shifting the Th1/Th17 to Treg immune responses during the development of anti-GBM GN. Here, TLR4 is linked to glioblastoma.